Dec 21, 2002|
Global markets: Volatile week
It was a volatile week for the US markets. Selling was the broad theme for the week. However, the Dow and NASDAQ recovered at the end of the week. Except for Monday and Friday the US markets were under a bear grip. On Monday, US markets showed signs of recovery after a poor performance last week. But Tuesday onwards the markets weakened as the Iraq issue started gaining more prominence. Investors seemed wary as the probability of war started looking more realistic. Yesterday however markets recovered, as holiday cheer deafened the war noises.
On the economic front, there was a dearth of news during the week. The complete analysis of the third quarter GDP growth indicates a 4% growth in line with earlier expectations. Apart from this, blue chip McDonalds warned of a first time ever loss in its quarterly performance. Oracle, on the other hand, beat analyst expectations by posting better than expected second quarter results this week. Both corporate and economic news are not pointing to a fast US economic recovery. Post holidays markets will face the yearly earnings season. US investors seem to have factored in the expected poor performance of corporate USA and may look to economic numbers to spur further investments.
Global market remained weak with the German market Dax falling by nearly 2%. Fears over a short-term war with Iraq have increased to an extent, and this is creating nervousness among investors. Investors seem to be shifting loyalties to the all time bell weather -- gold -- to revive their fortunes. Fears of a war have also led to a strong demand for crude thus inflating crude prices further.
|(Price in US $)
Except for Dr. Reddy’s and HDFC Bank the performance of Indian ADRs was either poor or lacklustre. Dr. Reddy’s gained significantly as a district court in New Jersey dismissed Pfizer's petition against Dr. Reddy’s regarding the patent term extension of its blockbuster drug Norvasc on Tuesday. Dr. Reddy’s will now be able to sell this generic drug in the US markets by August 2003. This drug had a market of US$ 2.1 bn in 2001.
Among the other major gainers, HDFC Bank spurred by nearly 8%. Software ADRs have been range bound in the current week. Infosys on the other hand, has been recovering from lower levels. The ADRs had witnessed correction after the company had announced issuance of more ADRs for the international markets. The range bound nature of Indian ADRs may continue, as there are no clear triggers for the US as well as the Indian markets.
This week Indian bourses saw the JPC report on the stock market scam in 2001 being tabled in the parliament. This created a bit of investor apprehension. Polaris’ chief was arrested then released from an Indonesian prison, while HCL Technologies bought out the software services business of HCL Infosystems. Software stocks may witness weakness on the Indian markets due to lack of news flow regarding large outsourcing contracts. Global markets may continue to remain range bound due to the holiday season, as investors may not want to take new positions before the New Year. Lack of positive triggers are likely to keep investors away from Indian markets.
More Views on News
Jun 10, 2017
Forty Indian investing gurus, as worthy of imitation as the legendary Peter Lynch, can help you get rich in the stock market.
Aug 21, 2017
Most Indians who cannot find jobs, look at becoming self-employed.
Aug 21, 2017
PersonalFN explains the chief factor pushing gold prices up of late.
Aug 21, 2017
One of the hallmarks of successful investing is to look out for companies that have a unique and enduring moat.
Aug 19, 2017
Ever heard of Lindy Effect? Find out how you can use it to pick timeless stocks.
More Views on News
Aug 10, 2017
Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.
Aug 8, 2017
'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'
Aug 8, 2017
Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...
Aug 12, 2017
The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.
Aug 10, 2017
Bitcoin hits an all-time high, is there more upside left?
Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement. LEGAL DISCLAIMER:
Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here
. The performance data quoted represents past performance and does not guarantee future results.SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: email@example.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407